-
Company Insights
NewDecoding Microsoft’s YouTube Advertising Strategy in Q1 2024
The report on Microsoft's advertising strategies on YouTube during the first quarter of 2024, focuses on key products such as Microsoft Copilot and its integration with post meeting recaps and PowerPoint presentations, followed by collaboration between Microsoft Azure Quantum and PNNL. It analyzes the core themes, messaging strategies, and product benefits portrayed in these advertisements, highlighting elements such as AI Integration, Time Management, Personalization and Collaboration. Moreover, the report examines the overarching themes of Innovation, Efficiency, Sustainability and Empowerment infused...
-
Sector Analysis
NewBronchiectasis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
Bronchiectasis Market Report Overview The Bronchiectasis market across the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) was valued at $1.4 billion in 2023 and the market will grow at a CAGR of more than 3% from 2023 to 2033. The 7MM (China, Japan, the United Kingdom, Spain, Italy, Germany, France, and the US). The market growth is attributed to the launch of brensocatib and an increase in the number of diagnosed prevalent cases of bronchiectasis. Bronchiectasis Market...
-
Sector Analysis
Head and Neck Squamous Cell Carcinomas (HNSCC) – Cell and Gene Therapies 15-Market Assessment and Sales Forecast to 2031
Head and Neck Squamous Cell Carcinomas (HNSCC) Market Report Overview The total market value for the 15M, which includes both cell and gene therapies and established/traditional HNSCC therapies was $1.9 billion in 2021. The growth is attributed to the established immune checkpoint inhibitors having a high ACOT. Head and Neck Squamous Cell Carcinomas (HNSCC) Market Outlook, 2021-2031 ($ Billion) Buy Full Report to Get More Insights into the HNSCC Market Forecast Download a Free Report Sample The HNSCC market research...
-
Sector Analysis
Glioblastoma Multiforme (GBM) – Cell and Gene Therapies 15-Market Assessment and Sales Forecast to 2031
Glioblastoma Multiforme (GBM) – Cell and Gene Therapies 15-Market Report Overview The total market value for the 15M, which includes both CGTs and established/traditional GBM therapies was $630 million in 2021. High usage of dendritic cell vaccines and oncolytic viruses that demonstrate significant survival advantages will drive market growth during the forecast period. Glioblastoma Multiforme (GBM) – Cell and Gene Therapies 15-Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Glioblastoma Multiforme (GBM) – Cell...
-
Sector Analysis
Acute Lymphocytic Leukemia (ALL) – Cell Therapies 15-Market Assessment and Sales Forecast to 2031
Acute Lymphocytic Leukemia (ALL) – Cell Therapies 15-Market Report Overview The total market value for the 15M, which includes both cell therapies and established/traditional ALL therapies was $2.3 billion in 2021. The need for “off-the-shelf” products with lower costs and reduced infrastructure requirements raises the development of allogeneic agents thereby driving the market growth. Acute Lymphocytic Leukemia (ALL) – Cell Therapies 15-Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Acute Lymphocytic Leukemia (ALL) –...
-
Sector Analysis
Chronic Lymphocytic Leukemia (CLL) – Cell Therapies 15-Market Assessment and Sales Forecast to 2031
Chronic Lymphocytic Leukemia (CLL) – Cell Therapies 15-Market Report Overview The total market value for the 15MM, which includes both cell therapies and established/traditional CLL therapies was $13.2 billion in 2021. Allogeneic stem cell transplant is becoming less popular due to high levels of morbidity and CAR-T seems an attractive replacement to induce long-term disease control. Chronic Lymphocytic Leukemia (CLL) – Cell Therapies 15-Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about Chronic Lymphocytic Leukemia (CLL)...
-
Sector Analysis
Multiple Myeloma – Cell Therapies 15-Market Assessment and Sales Forecast to 2031
Multiple Myeloma Cell Therapy Market Report Overview The total market value for the 15M, which includes both cell therapies and established/traditional MM therapies was $25.7 billion in 2021 The market growth will be attributed to the established CAR-T agents such as Abecma and Carvykt. Multiple Myeloma Cell Therapy Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Multiple Myeloma Cell Therapy Market Forecast Download a Free Report Sample The MM cell therapy market research report...
-
Sector Analysis
B-Cell Non-Hodgkins Lymphoma Cell Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2021-2031
B-Cell Non-Hodgkins Lymphoma Cell Therapy Market Report Overview The total market value for the 15M, which includes both cell therapies and established/traditional NHL therapies was $16.1 billion in 2021. The market growth will be attributed to the Kymriah, Yescarta, Breyanzi, and Carteyva, which will receive label expansions into earlier lines of therapy and new NHL subtypes. B-Cell Non-Hodgkins Lymphoma Cell Therapy Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the B-Cell Non-Hodgkins Lymphoma Cell Therapy...
-
Sector Analysis
Colorectal Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2031
Colorectal Cancer Cell and Gene Therapy Market Report Overview The CRC cell and gene therapy market size across the 15MM was $18.9 billion in 2021. The market growth will be attributed to the combination therapy of OVs + ICIs in dMMR/MSI-H patients in 2L and 3L settings. Colorectal Cancer Cell and Gene Therapy Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Colorectal Cancer Cell and Gene Therapy Market Forecast Download A Free Report Sample...
-
Thematic Analysis
Impact of Brazil on the Pharmaceutical Industry – Thematic Intelligence
Brazil Pharmaceutical Market Report Overview Brazil is the largest pharmaceutical market in Central/Southern America and is the 12th largest in the world. Brazil is an untapped market for big pharma manufacturing, with domestic companies dominating the marketed products landscape. The domestic pharmaceutical companies will continue to grow due to favorable policies provided by the Brazilian government to promote domestic production of medicines. Furthermore, over the years, Brazil has elevated its infrastructure, scientific, and technological facilities and has created a sustainable...